Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L threonine aldolase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114703169A reveals a novel L-threonine aldolase mutant for Droxidopa. Achieves 92.89% selectivity. Ideal for pharma intermediates supply.
Patent CN115109769B reveals L-threonine aldolase mutants enabling >99% conversion for L-serine synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN113337494B reveals high-purity enzymatic synthesis reducing waste and cost for reliable pharmaceutical intermediates supply chains globally.
Novel L-threonine aldolase enables green synthesis of antibiotic intermediates with high stereoselectivity and reduced environmental impact.
Patent CN115109769A reveals T202S/T202G mutants enabling >99% conversion at high formaldehyde concentrations for efficient L-serine production.